Opportunity
NIH Reporter #PA-21-050
Research Project Solicitation: Immunoediting in Cutaneous Squamous Cell Carcinoma for NCI
Buyer
National Cancer Institute (NCI), part of the NIH
Posted
October 04, 2023
Identifier
PA-21-050
NAICS
541715
This opportunity is issued by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), for a specialized research project on immunoediting in cutaneous squamous cell carcinoma (cSCC). - Government Buyer: - National Cancer Institute (NCI), National Institutes of Health (NIH) - Project Scope: - Research project titled 'Immunoediting in Cutaneous Squamous Cell Carcinoma' - Focuses on evaluating neoantigen profiles and immune escape mechanisms in cSCC - Includes both immunosuppressed and immunocompetent individuals - Potential for personalized vaccine development - Location: - University of Arizona, Tucson, AZ - Products/Services Requested: - Single research project (no specific part numbers or OEMs listed) - Quantity: 1 - Unique Requirements: - Emphasis on personalized medicine and immunological research - No specific licensing or classification requirements noted - Estimated Contract Value: - $55,114 - No OEMs or vendors are specified in the solicitation - No attachments or additional line items provided
Description
This project aims to evaluate neoantigen profiles and immune escape mechanisms in cutaneous squamous cell carcinoma from immunosuppressed and immunocompetent individuals. The research has potential applications in personalized vaccine development. The project is a research initiative conducted by the University of Arizona under the National Cancer Institute (NCI), part of the NIH. The award date is expected in 2026, with the project running from July 1, 2023, to August 31, 2027.